| Literature DB >> 15614224 |
Atsushi Fukuda1, Kichiro Koshida, Ichiro Yamaguchi, Masaaki Takahashi, Keitarou Kitabayashi, Kousuke Matsubara, Kimiya Noto, Chikako Kawabata, Hiroto Nakagawa.
Abstract
Various pharmaceutical companies in Japan are making radioactive drugs available for positron emission tomography (PET) in hospitals without a cyclotron. With the distribution of these drugs to hospitals, medical check-ups and examinations using PET are expected to increase. However, the safety guidelines for radiation in the new deployment of PET have not been adequately improved. Therefore, we measured the shielding effect of a clinical X-ray protector and lead glass against annihilation radiation and gamma rays of (99m)Tc. We then calculated the shielding effect of a 0.25 mm lead protector, 1 mm lead, and lead glass using the EGS4 (Electron Gamma Shower Version 4) code. The shielding effects of 22-mm lead glass against annihilation radiation and gamma rays of (99m)Tc were approximately 31.5% and 93.3%, respectively. The clinical X-ray protector against annihilation radiation approximately doubled the skin-absorbed dose.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15614224 DOI: 10.6009/jjrt.kj00003560637
Source DB: PubMed Journal: Nihon Hoshasen Gijutsu Gakkai Zasshi ISSN: 0369-4305